Leventakos, Konstantinos

Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRAS G12C Mutation

Jänne, P. A., Riely, G. J., Gadgeel, S. M., Heist, R. S., Ou, S.-H. I., Pacheco, J. M., Johnson, M. L., Sabari, J. K., Leventakos, K., Yau, E., et al. (2022) · New England Journal of Medicine

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

Cited by 1,061

Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance.

Ben-Ami, R., Garcia-Effron, G., Lewis, R. E., Gamarra, S., Leventakos, K., Perlin, D. S., & Kontoyiannis, D. P. (2011) · The Journal of Infectious Diseases

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 162

Collaborative Large Language Models for Automated Data Extraction in Living Systematic Reviews

Khan, M. A., Ayub, U., Naqvi, S. A. A., Khakwani, K. Z. R., Sipra, Z. B. R., Raina, A., Zou, S., He, H., Hossein, S. A., Hasan, B., et al. (2024) · Journal of the American Medical Informatics Association

Meta-analysis and systematic reviewsComputational and Text Analysis Methods

Cited by 54

Association of a remote patient monitoring (RPM) program with reduced hospitalizations in cancer patients with COVID-19

Pritchett, J. C., Borah, B. J., Desai, A. P., Xie, Z., Saliba, A. N., Leventakos, K., Coffey, J. D., Pearson, K. K., Speicher, L. L., Orenstein, R., et al. (2021) · JCO Oncology Practice

Telemedicine and Telehealth ImplementationCOVID-19 and healthcare impacts

Cited by 32

Early Changes in Circulating Cell-Free KRAS G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients

Paweletz, C. P., Heavey, G. A., Kuang, Y., Durlacher, E., Kheoh, T., Chao, R. C., Spira, A. I., Leventakos, K., Johnson, M. L., Ou, S.-H. I., et al. (2023) · Clinical Cancer Research

Cancer Genomics and DiagnosticsLung Cancer Treatments and Mutations

Cited by 23

JAB-3312, a Potent Allosteric SHP2 Inhibitor That Enhances the Efficacy of RTK/RAS/MAPK and PD-1 Blockade Therapies

Kang, D., Wang, Y., Lin, Y., Ma, W. W., Morgensztern, D., Leventakos, K., Bi, C., Ding, Y., Xiong, J., Yan, M., et al. (2025) · Clinical Cancer Research

Protein Tyrosine PhosphatasesMelanoma and MAPK Pathways

Cited by 17